Interestingly, EYA2 has recently been reported to influence TGF beta signaling in breast cancer cells [22], but in contrast to our findings in pancreatic cancer, these authors found that EYA2 functioned as a promoter of growth and metastases and a potential therapeutic target for inhibition. The gene discussed is EYA2; the disease is breast cancer.